Other OTC - Delayed Quote USD

Q BioMed Inc. (QBIO)

0.0002 0.0000 (0.00%)
At close: April 18 at 2:32 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Denis D. Corin Chairman, CEO & President 300k -- 1973
Mr. William S. Rosenstadt Chief Legal Officer, General Counsel & Director 300k -- 1968

Q BioMed Inc.

366 Madison Avenue
3rd Floor
New York, NY 10017
United States
212 588 0022 https://www.qbiomed.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Corporate Governance

Q BioMed Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 26, 2024 - May 30, 2024
Q BioMed Inc. Earnings Call

Related Tickers

AURX Nuo Therapeutics, Inc.
0.8000
0.00%
 
MRES Institute of Biomedical Research Corp.
0.0124
-6.06%
 
MCET MultiCell Technologies, Inc.
0.0000
0.00%
 
NAVB Navidea Biopharmaceuticals, Inc.
0.0376
+0.27%
 
PPCB Propanc Biopharma, Inc.
0.0011
+4.76%
 
GNPX Genprex, Inc.
2.1200
-4.07%
 
ACIU AC Immune SA
2.2900
-3.38%
 
PMN ProMIS Neurosciences, Inc.
1.9500
-2.99%
 
ERNA Eterna Therapeutics Inc.
1.7357
-2.49%
 
MORF Morphic Holding, Inc.
27.98
+1.05%